Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1Phase 1 1

Status

Completed 27Recruiting 8Active not recruiting 7Terminated 4Not yet recruiting 3Withdrawn 1Unknown 1Approved for marketing 1

Sponsor Class

OTHER 7INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1

Conditions

Colorectal Neoplasms 3Spinocerebellar Degenerations 1Small Cell Lung Carcinoma 1Neoplasm Metastasis 1

Interventions

pembrolizumab 184Carboplatin 130Paclitaxel 123Gemcitabine 122Docetaxel 96Cyclophosphamide 89Nivolumab 88Cisplatin 87Rituximab 71Dexamethasone 68Pemetrexed 64Bevacizumab 64Capecitabine 60atezolizumab 54fludarabine 49Azacitidine 49Fluorouracil 48130-nm albumin-bound paclitaxel 43venetoclax 41Trastuzumab 41Irinotecan 41Cetuximab 40Leucovorin 36Ipilimumab 36Erlotinib Hydrochloride 34Fulvestrant 32Cytarabine 32avelumab 31Oxaliplatin 31Albumin-Bound Paclitaxel 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × INDUSTRY × trifluridine tipiracil drug combination × Clear all
NCT05328908 2025-08-13

RELATIVITY-123

Bristol-Myers Squibb

Phase 3 Terminated
770 enrolled
Gastrointestinal

Spinocerebellar Degenerations, Colorectal Neoplasms

NCT01904253 2024-09-05

A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy

Taiho Oncology, Inc.

Phase 2 Terminated
18 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT05223673 2024-08-20

COLSTAR

Servier

Phase 3 Terminated
7 enrolled 12 charts
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT04073615 2024-05-02

A Study of Rivoceranib and Trifluridine/Tipiracil for Metastatic Colorectal Cancer (mCRC)

Elevar Therapeutics

Phase 1 Terminated
29 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡